Kymera Therapeutics, Inc. - KYMR

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$6.974B
QoQ value delta ($000)
+$2.44B (+53.83%)
Implied price effect (QoQ)
+37.47%
Shares
Total shares
89,638,045
QoQ shares delta
+9,533,080 (+11.9%)
Total shares held by funds (by quarter)

Market chart (KYMR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
FMR LLC 694,732 8,928,574 0.04%
BAKER BROS. ADVISORS LP 673,620 8,657,242 3.94%
Avoro Capital Advisors LLC 581,610 7,474,747 5.72%
VANGUARD GROUP INC 487,685 6,267,644 0.01%
PRICE T ROWE ASSOCIATES INC /MD/ 479,258 6,159,335 0.05%
BVF INC/IL 428,165 5,502,710 14.41%
BlackRock, Inc. 389,368 5,004,095 0.01%
Atlas Venture Life Science Advisors, LLC 362,584 4,659,874 41.91%
WELLINGTON MANAGEMENT GROUP LLP 343,370 4,412,933 0.06%
Siren, L.L.C. 255,748 3,286,830 7.63%
STATE STREET CORP 171,947 2,209,837 0.01%
Capital Research Global Investors 121,445 1,560,791 0.02%
GEODE CAPITAL MANAGEMENT, LLC 110,306 1,417,389 0.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 83,197 1,069,238 0.57%
ALLIANCEBERNSTEIN L.P. 74,080 952,065 0.02%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 71,001 912,498 0.02%
Merck & Co., Inc. 60,082 772,165 21.75%
FEDERATED HERMES, INC. 59,440 763,920 0.1%
Holocene Advisors, LP 59,229 761,209 0.12%
Commodore Capital LP 58,357 750,000 3.88%
GOLDMAN SACHS GROUP INC 57,603 740,306 0.01%
UBS Group AG 57,348 737,032 0.01%
FRONTIER CAPITAL MANAGEMENT CO LLC 49,483 635,957 0.53%
T. Rowe Price Investment Management, Inc. 49,001 629,745 0.03%
EVENTIDE ASSET MANAGEMENT, LLC 48,742 626,430 0.76%